Qin Tao, Qin Lian, Zhao Yang, Chen Yin, Liu Qianyue, Lin Xiaoguang, Lan Yongfeng, Huang Yaohui, Liu Yan, Zhang Ke, Pan Lifan, Li Jiaxiao, Duan Kunpeng, Liang Hao, Yin Mingjing, Fan Guiyang, Liu Lian, Deng Yu, Liao Lin, Su Danke, Gao Ming, Lu Junyu
Department of Emergency, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530201, China.
Intensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Adv Sci (Weinh). 2025 Aug;12(32):e17252. doi: 10.1002/advs.202417252. Epub 2025 Jun 29.
Sepsis induced acute liver injury (SALI), is a type of acute and severe disease that is generally characterized by producing significant amounts of reactive oxygen species (ROS) in liver tissue, and in response to excessive ROS, producing huge amounts of inflammatory factors by hepatocytes. Considering the crucial role of ROS in SALI, a Pd doped CeO (CP) nano-heterojunction with enhanced ROS scavenging capacity is developed to act as a catalytic nanomedicine for the treatment of SALI. Combining with near infrared (NIR) irradiation, it exhibits excellent scavenging capacity of ROS including hydroxyl radical (•OH), superoxide anion (•O ), as well as singlet oxygen (O) for CP. Significantly, it also demonstrates the excellent antioxidant and anti-inflammatory activities for lipopolysaccharides (LPS) stimulated macrophages (RAW264.7), and cecum ligation and puncture (CLP) treated C57BL/6J mice via reducing intracellular ROS levels, decreasing inflammatory factors expression levels, as well as activating Keap1/Nrf-2/HO-1 pathway to reprogram redox homeostasis, induce cellular autophagy, reduce systemic inflammation and promote liver tissue repair, finally achieving the alleviation of SALI. It provides a promising therapeutic strategy of CP+NIR with high efficacy and biosafety for the management of SALI.
脓毒症诱导的急性肝损伤(SALI)是一种急性重症疾病,其一般特征是在肝组织中产生大量活性氧(ROS),并且肝细胞会因过量ROS而产生大量炎性因子。鉴于ROS在SALI中的关键作用,开发了一种具有增强ROS清除能力的钯掺杂二氧化铈(CP)纳米异质结,用作治疗SALI的催化纳米药物。结合近红外(NIR)照射,它对CP表现出优异的ROS清除能力,包括羟基自由基(•OH)、超氧阴离子(•O )以及单线态氧(O)。值得注意的是,它还通过降低细胞内ROS水平、降低炎性因子表达水平以及激活Keap1/Nrf-2/HO-1通路来重新编程氧化还原稳态、诱导细胞自噬、减轻全身炎症并促进肝组织修复,从而对脂多糖(LPS)刺激的巨噬细胞(RAW264.7)以及盲肠结扎和穿刺(CLP)处理的C57BL/6J小鼠表现出优异的抗氧化和抗炎活性,最终实现SALI的缓解。它为SALI的管理提供了一种具有高疗效和生物安全性的CP+NIR的有前景的治疗策略。